# Ganoderma lucidum 'Chizhi'

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ganoderma-lucidum-chizhi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-05
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Red Reishi Chizhi, Chizhi Lingzhi, Red Ganoderma, Crimson Reishi, Red Lingzhi Mushroom, Chizhi Variant Reishi, Red Cultivar Ganoderma lucidum, Hongzhi Lingzhi, Red Varnish Shelf Fungus

## Overview

Ganoderma lucidum 'Chizhi' is a specific strain of red reishi mushroom whose primary bioactive compounds — branching beta-glucan polysaccharides and the [hepatoprotective](/ingredients/condition/detox) peptide GLP — drive its [immunomodulatory](/ingredients/condition/immune-support) and liver-protective effects. These compounds interact with immune cell receptors and [inflammatory](/ingredients/condition/inflammation) signaling cascades, though current evidence remains largely preclinical.

## Health Benefits

• [Anti-inflammatory](/ingredients/condition/inflammation) effects from polysaccharides (preclinical evidence only)
• Immunostimulating properties via [beta-glucan](/ingredients/condition/immune-support)s (in vitro studies)
• Potential antitumor activity through branching polysaccharide conformation (laboratory research)
• [Hepatoprotective](/ingredients/condition/detox) effects from peptide GLP (preclinical data)
• [Antioxidant activity](/ingredients/condition/antioxidant) attributed to bioactive proteins (preliminary evidence)

## Mechanism of Action

The branching [beta-glucan](/ingredients/condition/immune-support) polysaccharides in Ganoderma lucidum 'Chizhi' bind to Dectin-1 and complement receptor 3 (CR3) on macrophages and dendritic cells, triggering NF-κB and MAPK signaling pathways that upregulate [cytokine](/ingredients/condition/inflammation) production including TNF-α, IL-6, and IL-12. The [hepatoprotective](/ingredients/condition/detox) peptide GLP suppresses oxidative stress by modulating superoxide dismutase (SOD) and catalase activity while attenuating [lipid peroxidation](/ingredients/condition/antioxidant) in hepatocytes. Antitumor activity is mechanistically linked to the three-dimensional branching conformation of its polysaccharide chains, which enhances receptor binding affinity and promotes natural killer (NK) cell and cytotoxic T-lymphocyte activation.

## Clinical Summary

The majority of evidence supporting Ganoderma lucidum 'Chizhi' derives from in vitro cell studies and rodent preclinical models rather than randomized controlled trials in humans. Animal studies using standardized polysaccharide extracts at doses of 100–400 mg/kg have demonstrated statistically significant reductions in [inflammatory](/ingredients/condition/inflammation) markers (TNF-α, IL-1β) and measurable [hepatoprotective](/ingredients/condition/detox) effects under chemically induced liver injury models. A small number of human studies on broader Ganoderma lucidum species (not strain-specific to 'Chizhi') have shown modest immune cell count improvements in healthy adults, but these cannot be directly extrapolated to this variant. Overall, the evidence base is promising but insufficient to make definitive efficacy claims; large-scale, strain-specific clinical trials are absent.

## Nutritional Profile

Ganoderma lucidum 'Chizhi' (Red Reishi) is a woody, fibrous mushroom consumed primarily as an extract or supplement rather than as a culinary food, so traditional macronutrient values per 100 g of dried fruiting body are approximate. **Macronutrients (per 100 g dried):** Protein ~7–18 g (varies by substrate and cultivation conditions), total carbohydrates ~24–48 g (a large fraction being non-digestible polysaccharides), crude fat ~3–5 g, dietary fiber (chitin and beta-glucans) ~25–45 g, ash ~1–2 g, moisture ~10–13 g. Caloric value is low and largely irrelevant given typical dosing of 1–3 g/day as powder or extract. **Key Bioactive Compounds:** • Beta-glucans (primarily β-1,3/1,6-D-glucans): ~25–50% of dry weight in polysaccharide-enriched extracts; responsible for [immunomodulatory](/ingredients/condition/immune-support) activity; oral bioavailability is limited—beta-glucans are not fully absorbed intact but interact with gut-associated lymphoid tissue (Peyer's patches) and dectin-1 receptors on macrophages. • Ganoderic acids (triterpenoids, lanostane-type): over 150 identified; total triterpenoid content ~3–5% of dried fruiting body; key species include ganoderic acids A, B, C, D, F, and lucidenic acids; these are lipophilic and moderately bioavailable, enhanced by co-administration with lipids or ethanol extraction. • Ganoderma lucidum peptide (GLP): a fungal immunomodulatory protein (~15 kDa); present in trace amounts; [hepatoprotective](/ingredients/condition/detox) and [antioxidant](/ingredients/condition/antioxidant) in preclinical models; oral bioavailability is uncertain and likely low due to gastrointestinal proteolysis. • Polysaccharide-protein complexes (proteoglycans): water-soluble; ~10–15% of hot-water extract; branching conformation correlates with antitumor bioactivity. • Sterols: ergosterol ~0.3–0.5% of dry weight (provitamin D₂; convertible to vitamin D₂ upon UV exposure). • Nucleosides and nucleotides: adenosine ~0.01–0.05%; trace uridine and guanosine. **Minerals (per 100 g dried, approximate):** Potassium ~1,500–2,000 mg, phosphorus ~400–600 mg, calcium ~30–70 mg, magnesium ~60–120 mg, selenium ~2–10 µg (substrate-dependent; selenium-enriched cultivars can reach ~50–100 µg), zinc ~5–9 mg, iron ~3–8 mg, copper ~1–2 mg, germanium (organic; trace, ~40–120 µg reported in some analyses—historically emphasized but amounts are very small). **Vitamins:** Vitamin D₂ (ergocalciferol) is negligible unless UV-treated; B-vitamins are present in small amounts—niacin (B₃) ~3–5 mg, riboflavin (B₂) ~0.2–0.5 mg, thiamine (B₁) ~0.1–0.2 mg per 100 g dried. Vitamin C is essentially absent. **Other Bioactives:** Phenolic compounds (total phenolics ~5–15 mg GAE/g extract), small molecular weight antioxidant peptides, lectins (e.g., GLL, ~15 kDa), and laccases. **Bioavailability Notes:** Water extraction preferentially yields polysaccharides/beta-glucans; ethanol or dual extraction captures triterpenoids. Spore-cracked preparations improve triterpenoid release (intact spore wall is largely indigestible). Polysaccharide bioactivity is structure-dependent—higher molecular weight and greater branching correlate with stronger immunostimulatory effects but lower direct absorption; systemic effects are believed to be largely gut-immune mediated rather than via direct bloodstream absorption. Triterpenoid absorption benefits from lipid-based delivery systems.

## Dosage & Preparation

No clinically studied dosage ranges are established for 'Chizhi'. Traditional preparations involve simmering dried fruiting body in water for 2 hours or using powder by inch-square spoonfuls. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ganoderma lucidum 'Chizhi' is generally considered well-tolerated in short-term use, with reported side effects including mild gastrointestinal discomfort, dry mouth, and dizziness, particularly at higher doses. Due to its immunostimulating properties via [beta-glucan](/ingredients/condition/immune-support) activation, it may theoretically interfere with immunosuppressant medications such as cyclosporine or corticosteroids, potentially diminishing their efficacy. Its documented effects on platelet aggregation and coagulation pathways raise caution for concurrent use with anticoagulants like warfarin or antiplatelet drugs such as aspirin and clopidogrel. Insufficient safety data exist for pregnant or breastfeeding individuals, and use during these periods should be avoided unless supervised by a qualified healthcare provider.

## Scientific Research

The research dossier reveals a lack of specific human clinical trials for Ganoderma lucidum 'Chizhi'. General reviews cite mostly preclinical or in vitro studies (Miyazaki and Nishijima 1981; Bao et al. 2001) demonstrating bioactivities, but no RCTs with study design, sample size, or human outcomes are available.

## Historical & Cultural Context

In Traditional Chinese Medicine, Ganoderma lucidum including red variants like 'Chizhi' has been revered for over 2,000 years as the 'mushroom of immortality,' used to promote [longevity](/ingredients/condition/longevity), vitality, and spiritual enlightenment. Red types were particularly preferred in Japan and South China for supporting internal organs, [memory](/ingredients/condition/cognitive), and vitality.

## Synergistic Combinations

Other Ganoderma species, Cordyceps, Turkey Tail, Shiitake, Vitamin D3

## Frequently Asked Questions

### What makes Ganoderma lucidum Chizhi different from regular reishi mushroom?

Ganoderma lucidum 'Chizhi' is a taxonomically distinct strain characterized by a specific branching polysaccharide conformation that may enhance receptor binding at Dectin-1 and CR3 immune receptors compared to other reishi variants. It also contains the peptide GLP, which has shown hepatoprotective activity in preclinical models, a compound not consistently isolated or studied across all Ganoderma species and strains. These structural and biochemical distinctions mean that research on generic reishi extracts cannot be assumed to apply equally to the 'Chizhi' strain.

### What is the studied dosage of Ganoderma lucidum Chizhi polysaccharide extract?

Preclinical rodent studies investigating the anti-inflammatory and hepatoprotective effects of Ganoderma lucidum 'Chizhi' polysaccharide extracts have used doses ranging from 100 to 400 mg/kg body weight. No established human clinical dosage has been validated specifically for this strain through controlled trials. General reishi supplement guidelines in human studies typically range from 1,000 to 3,000 mg of standardized extract daily, but these should not be directly applied to 'Chizhi' without strain-specific human data.

### Can Ganoderma lucidum Chizhi help with liver health?

The peptide GLP isolated from Ganoderma lucidum 'Chizhi' has demonstrated hepatoprotective properties in preclinical models, specifically by enhancing antioxidant enzyme activity — including superoxide dismutase (SOD) and catalase — and reducing lipid peroxidation in hepatocytes under chemically induced stress conditions. These effects suggest a protective mechanism against oxidative liver damage rather than a reversal of established liver disease. However, no human clinical trials have confirmed these hepatoprotective effects for this strain, so it should not replace evidence-based liver therapies.

### Is Ganoderma lucidum Chizhi safe to take with blood thinners?

Ganoderma lucidum compounds have been shown in preclinical studies to inhibit platelet aggregation and alter coagulation pathways, which creates a potential drug interaction risk with anticoagulants such as warfarin and antiplatelet agents including aspirin, clopidogrel, and NSAIDs. Concurrent use could theoretically increase bleeding risk or potentiate the effects of these medications beyond therapeutic targets. Anyone prescribed anticoagulant or antiplatelet therapy should consult their physician before using any Ganoderma lucidum supplement, including the 'Chizhi' strain.

### Does Ganoderma lucidum Chizhi have antitumor properties?

Laboratory research has shown that the branching beta-glucan polysaccharides from Ganoderma lucidum 'Chizhi' can promote NK cell and cytotoxic T-lymphocyte activation, and inhibit tumor cell proliferation in in vitro models, partly through modulation of NF-κB signaling. The three-dimensional branching conformation of its polysaccharide chains appears to be a key structural feature that enhances binding to immune cell receptors and triggers antitumor immune responses. These findings are exclusively preclinical, and no human clinical trials have established that 'Chizhi' supplementation can prevent, treat, or reduce cancer in humans.

### What is the difference between Ganoderma lucidum Chizhi extract and whole fruiting body supplements?

Chizhi extracts concentrate polysaccharides and bioactive peptides (like GLP) through standardization, whereas whole fruiting body supplements contain the full spectrum of compounds at lower concentrations. Extracts typically deliver higher amounts of the studied beta-glucans and branching polysaccharides associated with immunostimulating and antioxidant effects. The extraction process can significantly influence bioavailability and the concentration of researched compounds, making extracts the preferred form in most clinical investigations.

### Who should consider taking Ganoderma lucidum Chizhi supplements?

Individuals interested in immune support and antioxidant protection may benefit from Chizhi supplementation, particularly those in high-stress environments or with seasonal wellness concerns. People seeking hepatic support may also find it relevant due to preclinical evidence for the peptide GLP's hepatoprotective properties. However, those on anticoagulant medications or with bleeding disorders should consult a healthcare provider before use.

### How strong is the scientific evidence supporting Ganoderma lucidum Chizhi's health claims?

Current evidence for Chizhi is primarily preclinical and in vitro, meaning studies have been conducted in laboratory and animal models rather than large-scale human trials. The anti-inflammatory, immunostimulating, and antioxidant properties show promise in preliminary research, but human clinical data remains limited. This ingredient would benefit from additional randomized controlled trials to establish efficacy and optimal dosing in human populations.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*